Synthesis, in silico and biodistribution studies of a novel 47Sc-radiolabeled α-amino acid ester derivative attached to pyrazine and tetrazole rings for tumor targeted radiotherapy

IF 1.4 3区 化学 Q4 CHEMISTRY, INORGANIC & NUCLEAR
Mohamed A. Gizawy, Hesham A. Shamsel-Din, Mohsen M. T. El-Tahawy, Ayman A. Ibrahim
{"title":"Synthesis, in silico and biodistribution studies of a novel 47Sc-radiolabeled α-amino acid ester derivative attached to pyrazine and tetrazole rings for tumor targeted radiotherapy","authors":"Mohamed A. Gizawy, Hesham A. Shamsel-Din, Mohsen M. T. El-Tahawy, Ayman A. Ibrahim","doi":"10.1515/ract-2023-0175","DOIUrl":null,"url":null,"abstract":"Recently, tumor-targeted radionuclide therapy has gained much recognition for the treatment of metastasized cancer. There is a growing interest in using the theranostic radionuclide <jats:sup>47</jats:sup>Sc, owing to its excellent chemical and nuclear properties. However, the available chelating agents require a relatively high temperature for their radiolabeling, which could denature biomolecules. The aim of the present study is to synthesize a dipeptide agent that forms a thermodynamically more stable complex with <jats:sup>47</jats:sup>Sc at room temperature. A novel <jats:italic>α</jats:italic>-amino acid ester derivative attached to pyrazine and tetrazole heterocyclic rings has been prepared by the azide coupling method. Different spectroscopic methods (FT-IR, <jats:sup>1</jats:sup>H NMR, and mass spectra) were used for characterization of the target compound. The newly synthesized dipeptide was radiolabeled with <jats:sup>47</jats:sup>Sc, and a high radiochemical yield of 98.5 ± 1.5 % and <jats:italic>in vitro</jats:italic> serum stability up to 72 h were attained at room temperature within 20 min. The quantum chemical calculations at B3PW91/6-31G(d) level were employed to establish the molecular structure of the dipeptide and its complexation with <jats:sup>47</jats:sup>Sc. The selectivity of <jats:sup>47</jats:sup>Sc-dipeptide toward localization in tumor cells was performed by molecular docking on different receptors in addition to <jats:italic>in vivo</jats:italic> biodistribution on solid tumor-bearing mice. A high T/NT ratio of 8.16 was obtained after 4 h p.i, suggesting that this complex could be used as a potential cancer theranostic agent.","PeriodicalId":21167,"journal":{"name":"Radiochimica Acta","volume":"24 1","pages":""},"PeriodicalIF":1.4000,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiochimica Acta","FirstCategoryId":"92","ListUrlMain":"https://doi.org/10.1515/ract-2023-0175","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, INORGANIC & NUCLEAR","Score":null,"Total":0}
引用次数: 0

Abstract

Recently, tumor-targeted radionuclide therapy has gained much recognition for the treatment of metastasized cancer. There is a growing interest in using the theranostic radionuclide 47Sc, owing to its excellent chemical and nuclear properties. However, the available chelating agents require a relatively high temperature for their radiolabeling, which could denature biomolecules. The aim of the present study is to synthesize a dipeptide agent that forms a thermodynamically more stable complex with 47Sc at room temperature. A novel α-amino acid ester derivative attached to pyrazine and tetrazole heterocyclic rings has been prepared by the azide coupling method. Different spectroscopic methods (FT-IR, 1H NMR, and mass spectra) were used for characterization of the target compound. The newly synthesized dipeptide was radiolabeled with 47Sc, and a high radiochemical yield of 98.5 ± 1.5 % and in vitro serum stability up to 72 h were attained at room temperature within 20 min. The quantum chemical calculations at B3PW91/6-31G(d) level were employed to establish the molecular structure of the dipeptide and its complexation with 47Sc. The selectivity of 47Sc-dipeptide toward localization in tumor cells was performed by molecular docking on different receptors in addition to in vivo biodistribution on solid tumor-bearing mice. A high T/NT ratio of 8.16 was obtained after 4 h p.i, suggesting that this complex could be used as a potential cancer theranostic agent.
用于肿瘤靶向放射治疗的新型 47Sc 放射标记α-氨基酸酯衍生物的合成、硅学和生物分布研究
最近,肿瘤靶向放射性核素疗法在治疗转移性癌症方面获得了广泛认可。由于 47Sc 具有优异的化学和核特性,人们对使用治疗放射性核素的兴趣与日俱增。然而,现有的螯合剂需要在相对较高的温度下进行放射性标记,这可能会使生物大分子变性。本研究的目的是合成一种能在室温下与 47Sc 形成热力学上更稳定的复合物的二肽剂。本研究采用叠氮偶联法制备了一种新型α-氨基酸酯衍生物,该衍生物附着在吡嗪和四唑杂环上。目标化合物的表征采用了不同的光谱方法(傅立叶变换红外光谱、1H NMR 和质谱)。用 47Sc 对新合成的二肽进行了放射性标记,在室温下 20 分钟内达到了 98.5 ± 1.5 % 的高放射化学收率和长达 72 小时的体外血清稳定性。通过 B3PW91/6-31G(d) 水平的量子化学计算,建立了二肽的分子结构及其与 47Sc 的复合物。除了在实体瘤小鼠体内的生物分布外,还通过与不同受体的分子对接研究了 47Sc 二肽在肿瘤细胞中的定位选择性。4 h p.i后,T/NT比值高达8.16,这表明该复合物可用作一种潜在的癌症治疗剂。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Radiochimica Acta
Radiochimica Acta 化学-核科学技术
CiteScore
2.90
自引率
16.70%
发文量
78
审稿时长
6 months
期刊介绍: Radiochimica Acta publishes manuscripts encompassing chemical aspects of nuclear science and technology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信